The University of Chicago Header Logo

Summer Hanson

Concepts (243)

Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.


Name Number of Publications Most Recent Publication Publications by All Authors Concept Score Why?
Mammaplasty
20
2023
109
8.890
Why?
Adipose Tissue
20
2022
246
7.110
Why?
Breast Neoplasms
24
2024
2961
3.360
Why?
Transplantation, Autologous
16
2022
340
2.730
Why?
Mastectomy, Segmental
5
2023
93
2.040
Why?
Breast Implants
5
2020
25
1.940
Why?
Mesenchymal Stem Cell Transplantation
5
2013
56
1.590
Why?
Adipocytes
3
2022
155
1.580
Why?
Venous Thrombosis
3
2018
249
1.540
Why?
Lymphedema
2
2022
77
1.470
Why?
Mastectomy
11
2023
243
1.390
Why?
Breast
9
2022
289
1.380
Why?
Lymphoma, Large-Cell, Anaplastic
4
2020
9
1.350
Why?
Anastomosis, Surgical
3
2018
267
1.310
Why?
Free Tissue Flaps
4
2021
49
0.960
Why?
Tissue and Organ Harvesting
3
2021
79
0.950
Why?
Tissue Scaffolds
3
2014
107
0.920
Why?
Fat Necrosis
1
2022
6
0.870
Why?
Humans
59
2024
87465
0.870
Why?
Postoperative Complications
7
2022
2234
0.830
Why?
Microsurgery
4
2022
85
0.830
Why?
Face
1
2022
115
0.820
Why?
Tissue Engineering
5
2021
182
0.780
Why?
Wound Healing
3
2013
348
0.760
Why?
Ki-1 Antigen
1
2020
17
0.720
Why?
Lipectomy
1
2019
9
0.680
Why?
Female
35
2024
45140
0.670
Why?
Enzyme-Linked Immunosorbent Assay
1
2020
378
0.660
Why?
Patient Education as Topic
1
2021
352
0.650
Why?
Acellular Dermis
1
2018
4
0.650
Why?
Tissue Expansion
1
2018
19
0.640
Why?
Breast Implantation
1
2018
13
0.640
Why?
Mass Screening
1
2022
624
0.610
Why?
Macrophages
4
2013
570
0.580
Why?
Immunophenotyping
3
2013
213
0.580
Why?
Abdominal Fat
2
2013
13
0.580
Why?
Middle Aged
18
2022
25302
0.530
Why?
Hydrogel, Polyethylene Glycol Dimethacrylate
2
2013
31
0.510
Why?
Bone Marrow Cells
2
2013
257
0.500
Why?
Hyaluronic Acid
2
2013
49
0.500
Why?
Prospective Studies
8
2022
4230
0.490
Why?
Immunomodulation
1
2014
55
0.490
Why?
Skin
3
2019
561
0.450
Why?
Retrospective Studies
14
2022
8701
0.440
Why?
Biocompatible Materials
1
2014
196
0.440
Why?
Perforator Flap
2
2022
12
0.420
Why?
Autografts
3
2021
28
0.420
Why?
Cell Lineage
1
2013
287
0.410
Why?
Adult
18
2021
25988
0.410
Why?
Aged
14
2021
18609
0.380
Why?
Tracheal Diseases
1
2010
13
0.380
Why?
Laryngeal Diseases
1
2010
20
0.370
Why?
Filtration
2
2021
25
0.370
Why?
Time and Motion Studies
2
2021
21
0.370
Why?
Vocal Cords
1
2010
26
0.360
Why?
Seroma
2
2020
7
0.340
Why?
Propensity Score
2
2021
140
0.340
Why?
Follow-Up Studies
9
2020
3638
0.330
Why?
Skin Diseases
1
2010
170
0.310
Why?
Surgery, Plastic
2
2021
42
0.290
Why?
Fibroblasts
1
2010
736
0.290
Why?
Wounds and Injuries
1
2010
235
0.290
Why?
Flow Cytometry
4
2013
686
0.290
Why?
Time Factors
6
2020
5258
0.280
Why?
Head and Neck Neoplasms
3
2019
1057
0.270
Why?
Neoplasms
1
2021
2966
0.270
Why?
Coculture Techniques
4
2013
166
0.260
Why?
Cells, Cultured
6
2013
2842
0.260
Why?
Patient Preference
2
2023
105
0.250
Why?
Axilla
1
2024
102
0.230
Why?
Young Adult
6
2021
6112
0.230
Why?
Cell Differentiation
5
2013
1501
0.230
Why?
Treatment Outcome
5
2022
8051
0.220
Why?
Trauma Centers
2
2015
116
0.210
Why?
Lymph Node Excision
1
2024
220
0.210
Why?
Mammary Arteries
1
2022
31
0.210
Why?
Shoulder
1
2022
42
0.210
Why?
Dietary Supplements
1
2022
128
0.210
Why?
Myocutaneous Flap
1
2021
5
0.200
Why?
Arm
1
2022
96
0.200
Why?
Community Participation
1
2021
36
0.200
Why?
Patient Satisfaction
2
2022
456
0.200
Why?
Embolism, Fat
1
2021
2
0.200
Why?
Centrifugation
1
2021
24
0.200
Why?
Drainage
1
2022
157
0.200
Why?
Lymphangiogenesis
1
2021
39
0.190
Why?
Clothing
1
2020
7
0.180
Why?
Rectus Abdominis
2
2010
40
0.180
Why?
Physicians, Women
1
2020
55
0.180
Why?
Cadaver
2
2018
185
0.180
Why?
Aged, 80 and over
6
2021
6606
0.170
Why?
Nipples
1
2019
37
0.170
Why?
Quality of Life
3
2022
1628
0.170
Why?
Organ Sparing Treatments
1
2019
42
0.170
Why?
Skin Transplantation
2
2010
179
0.170
Why?
Time-to-Treatment
1
2020
102
0.170
Why?
Subcutaneous Fat
1
2018
19
0.160
Why?
Freeze Drying
1
2018
14
0.160
Why?
Surgical Wound Dehiscence
1
2018
37
0.160
Why?
Operating Rooms
1
2019
127
0.160
Why?
Endothelial Cells
1
2021
448
0.160
Why?
Surgical Flaps
2
2010
245
0.160
Why?
Graft Survival
2
2021
901
0.150
Why?
Education, Medical
1
2020
238
0.150
Why?
Treatment Failure
1
2018
284
0.150
Why?
Microvessels
1
2017
69
0.150
Why?
Epinephrine
1
2017
85
0.150
Why?
Lidocaine
1
2017
64
0.150
Why?
Health Knowledge, Attitudes, Practice
1
2021
514
0.150
Why?
Suture Techniques
1
2017
135
0.140
Why?
Anesthetics, Local
1
2017
76
0.140
Why?
Surgeons
1
2020
239
0.140
Why?
Esthetics
2
2020
46
0.140
Why?
Surgical Wound Infection
1
2018
189
0.140
Why?
Pilot Projects
1
2019
854
0.140
Why?
Mammography
1
2019
465
0.140
Why?
Male
9
2021
41449
0.130
Why?
Patient Readmission
1
2019
340
0.130
Why?
Students, Medical
1
2020
395
0.130
Why?
Quality Improvement
1
2019
431
0.130
Why?
Facial Injuries
1
2015
19
0.130
Why?
Reproducibility of Results
2
2020
2733
0.130
Why?
Pain, Postoperative
1
2017
245
0.120
Why?
Foreign-Body Reaction
1
2014
11
0.120
Why?
Wounds, Nonpenetrating
1
2015
91
0.120
Why?
Neoplasm Recurrence, Local
2
2021
1343
0.120
Why?
Radiotherapy, Adjuvant
2
2015
294
0.120
Why?
Clinical Protocols
1
2014
156
0.120
Why?
Receptors, Fibroblast Growth Factor
1
2013
16
0.120
Why?
Gelatin
1
2013
25
0.110
Why?
Swine, Miniature
1
2013
51
0.110
Why?
Reoperation
2
2019
603
0.110
Why?
Cell Separation
1
2013
195
0.110
Why?
Sus scrofa
1
2013
48
0.110
Why?
Internship and Residency
2
2020
1028
0.110
Why?
Tomography, X-Ray Computed
2
2015
2616
0.110
Why?
Fibroblast Growth Factors
1
2013
81
0.110
Why?
Adolescent
3
2021
9075
0.110
Why?
Epidermis
1
2013
101
0.110
Why?
Device Removal
2
2013
166
0.110
Why?
Cell Communication
1
2013
196
0.110
Why?
Surgicenters
1
2011
5
0.100
Why?
Mannose-Binding Lectins
1
2011
6
0.100
Why?
Lipopolysaccharide Receptors
1
2011
23
0.100
Why?
HLA-DR Antigens
1
2011
59
0.100
Why?
Antigens, CD
1
2013
462
0.100
Why?
Swine
1
2013
570
0.100
Why?
Respiration, Artificial
1
2014
344
0.100
Why?
Maxillofacial Injuries
1
2011
4
0.100
Why?
Reverse Transcriptase Polymerase Chain Reaction
1
2013
887
0.100
Why?
Skull Fractures
1
2011
24
0.100
Why?
Receptors, IgG
1
2011
52
0.100
Why?
Lectins, C-Type
1
2011
85
0.100
Why?
Interdisciplinary Communication
1
2011
130
0.100
Why?
Rejuvenation
1
2010
20
0.100
Why?
Polymerase Chain Reaction
1
2013
925
0.090
Why?
Regenerative Medicine
1
2010
24
0.090
Why?
Cooperative Behavior
1
2011
177
0.090
Why?
Transplantation, Homologous
1
2013
994
0.090
Why?
Peripheral Vascular Diseases
1
2010
61
0.090
Why?
Monocytes
1
2011
217
0.090
Why?
Receptors, Cell Surface
1
2011
289
0.090
Why?
Adipogenesis
1
2009
37
0.090
Why?
Patient Care Team
1
2011
280
0.090
Why?
Academic Medical Centers
1
2011
380
0.080
Why?
Regeneration
1
2010
147
0.080
Why?
Cell Culture Techniques
1
2009
188
0.080
Why?
Monitoring, Physiologic
1
2010
264
0.080
Why?
Cell Survival
1
2011
977
0.080
Why?
Disease Models, Animal
2
2013
2299
0.080
Why?
Islets of Langerhans
1
2012
546
0.080
Why?
In Vitro Techniques
1
2010
993
0.080
Why?
Cell Membrane
1
2011
667
0.080
Why?
Extracellular Matrix
1
2009
242
0.080
Why?
Interferon-gamma
1
2010
445
0.080
Why?
Mutation
1
2019
4060
0.080
Why?
Gene Expression Regulation
2
2013
1956
0.080
Why?
Glucose
1
2010
626
0.070
Why?
Stem Cells
1
2009
364
0.070
Why?
Biomarkers
1
2013
1731
0.070
Why?
Phenotype
1
2013
2414
0.070
Why?
Chronic Disease
1
2010
942
0.070
Why?
Animals
3
2014
26935
0.070
Why?
Sentinel Lymph Node Biopsy
1
2024
69
0.060
Why?
Ribs
1
2022
45
0.050
Why?
Delphi Technique
1
2022
83
0.050
Why?
Lymphatic Metastasis
1
2024
497
0.050
Why?
Disease-Free Survival
2
2015
1208
0.050
Why?
Prognosis
2
2019
3706
0.050
Why?
Buttocks
1
2021
10
0.050
Why?
Neoadjuvant Therapy
1
2024
337
0.050
Why?
Consensus
1
2022
345
0.050
Why?
Combined Modality Therapy
1
2024
1695
0.050
Why?
Lymph Nodes
1
2024
545
0.050
Why?
Survivorship
1
2020
19
0.050
Why?
Elasticity
1
2019
94
0.040
Why?
Needs Assessment
1
2020
155
0.040
Why?
Neoplasm Staging
1
2024
1960
0.040
Why?
Cancer Survivors
1
2020
89
0.040
Why?
Gene Expression
2
2013
1296
0.040
Why?
BRCA2 Protein
1
2019
159
0.040
Why?
Single-Blind Method
1
2018
148
0.040
Why?
Inpatients
1
2021
306
0.040
Why?
Biomechanical Phenomena
1
2019
461
0.040
Why?
BRCA1 Protein
1
2019
201
0.040
Why?
Cell Proliferation
2
2013
1620
0.040
Why?
United States
2
2021
6763
0.030
Why?
Glasgow Coma Scale
1
2015
67
0.030
Why?
Drug Therapy, Combination
1
2017
794
0.030
Why?
Ventilator Weaning
1
2014
24
0.030
Why?
Chemotherapy, Adjuvant
1
2015
473
0.030
Why?
Drug Therapy
1
2013
70
0.030
Why?
Disease Management
1
2015
321
0.030
Why?
Kaplan-Meier Estimate
1
2015
855
0.030
Why?
Watchful Waiting
1
2013
60
0.030
Why?
Child
2
2015
7035
0.030
Why?
Double-Blind Method
1
2017
1706
0.030
Why?
Extracellular Matrix Proteins
1
2013
124
0.030
Why?
Intercellular Signaling Peptides and Proteins
1
2013
181
0.030
Why?
Antigens, Surface
1
2012
103
0.030
Why?
Capital Financing
1
2011
4
0.030
Why?
Facility Design and Construction
1
2011
4
0.030
Why?
Fees, Medical
1
2011
10
0.030
Why?
Group Practice
1
2011
7
0.030
Why?
Wisconsin
1
2011
39
0.030
Why?
Surveys and Questionnaires
1
2020
2552
0.030
Why?
Incidence
1
2016
1567
0.020
Why?
Trauma Severity Indices
1
2011
42
0.020
Why?
Intensive Care Units
1
2014
379
0.020
Why?
Length of Stay
1
2014
713
0.020
Why?
Logistic Models
1
2014
1194
0.020
Why?
Veins
1
2010
95
0.020
Why?
Constriction, Pathologic
1
2010
216
0.020
Why?
Arteries
1
2010
178
0.020
Why?
Cytokines
1
2013
794
0.020
Why?
Infant, Newborn
1
2015
2423
0.020
Why?
Risk Factors
1
2019
5365
0.020
Why?
Infant
1
2015
3095
0.020
Why?
Child, Preschool
1
2015
3648
0.020
Why?
Gene Expression Profiling
1
2013
1410
0.020
Why?
Cell Line, Tumor
1
2013
2494
0.020
Why?
Rats, Sprague-Dawley
1
2010
1222
0.020
Why?
Rats
1
2010
4012
0.010
Why?
Hanson's Networks
Click the
Explore
buttons for more information and interactive visualizations!
Concepts (243)
Explore
_
Co-Authors (3)
Explore
_
Similar People (60)
Explore
_
Same Department Expand Description
Explore
_
Physical Neighbors
_